Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic.

ABSTRACT:

Objective/background

No research has yet assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on restless legs syndrome (RLS). We hypothesized that RLS symptom severity would be increased during the COVID-19 pandemic in a sample of patients with diagnosed RLS.

Patients/methods

The National RLS Opioid Registry is a longitudinal observational study of patients using opioid medications for treatment of RLS. Questionnaires assessing RLS symptom severity, medication dosages, sleep disturbance, depression, and anxiety are administered at baseline and at recurring 6-month surveys. Survey responses from the outset of the pandemic in April/May 2020 were compared to responses completed by other participants in January/February 2020 (between-subjects analysis), as we

SUBMITTER: Wipper B 

PROVIDER: S-EPMC8783980 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature